C.R. Bard IVC Filter Lawsuits Progressing, As MDL Court Convenes First Scheduling Conference, Bernstein Liebhard LLP Reports

November 02, 2015 (PRLEAP.COM) Business News
November 2, 2015 - More than 50 IVC filter lawsuits (http://www.ivcfilterlawsuit2015.com/) filed against C.R. Bard, Inc. are moving forward in a multidistrict litigation now underway in the U.S. District Court, District of Arizona. According to court documents, the proceeding's first scheduling conference was convened on October 29th, at which time the Court addressed a number of matters, including the structure of Plaintiffs' leadership, the scope of discovery, and the handling of advanced cases that are nearly ready for trial. Minutes from the proceeding also indicate that the Court has scheduled a Status Hearing for January 29th, 2016. A joint discovery report is due on January 20th. (In Re: Bard IVC Filters Products Liability Litigation MDL No. 2641)

"Our Firm has heard from a number of individuals who allegedly suffered perforations of the inferior vena cava and other serious harm due to Bard's Recovery and G2 IVC filter products. We are pleased to see the federal litigation progressing, and will be monitoring events closely," says Sandy A. Liebhard LLP, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently evaluating IVC filter lawsuits on behalf of individuals who may have been seriously injured by these devices.

IVC Filter Litigation
The Recovery and G2 IVC filters are retrievable devices that are implanted into the inferior vena cava in order to catch blood clots before they can travel to the lungs and become a pulmonary embolism. Failure to retrieve an IVC filter greatly increases the risk of injury and complications, but plaintiffs who have filed claims against C.R. Bard accuse the company of failing to provide doctors with adequate warnings regarding the importance of removal. They also charge that the filters are associated with high rates of fracture, migration and tilting, which may result in perforation of the inferior vena cava, embolization and other life-threatening complications.

The Bard Recovery IVC Filter was brought to market in 2003, but replaced by the G2 device in 2005. A report that aired on the NBC Nightly News in September suggested that C.R. Bard was aware that the Recovery filter was associated with higher rates of death, fracture and movement compared to its competitors, but chose not to recall the device. Instead, the company replaced the Recovery IVC Filter with a modified version, the G2.

Bernstein Liebhard LLP is now offering free IVC lawsuit reviews to individuals who suffered complications allegedly associated with C.R. Bard's Recovery or G2 devices. To learn more, please visit the Firm's website, or call 800-511-5092 to arrange for a free, no-obligation legal consultation.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. The Firm was named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list for a dozen consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP

Share Article